Tag: Biologicals for Systemic Lupus Erythematosus Market

Biologicals for Systemic Lupus Erythematosus Market Trends And Drivers The Biologicals for Systemic Lupus Erythematosus (SLE) market was valued at approximately USD 5.3 Billion in 2022 and is projected to reach USD 12.4 Billion by 2030, growing at a CAGR of 11.3% from 2024 to 2030. The rising prevalence of SLE, coupled with the increasing […]